Abbott Laboratories Stock Drops 4% Over Decline In Q1 Earnings

Abbott Laboratories reported first-quarter earnings of $1.07 billion, or $0.61 per share, down from $1.32 billion, or $0.76 per share a year earlier. The earnings decline is weighing on the stock, which is down about 4% in Thursday morning trading. The report points to weaker near-term fundamentals, though no guidance details were provided.

Analysis

Abbott Laboratories reported first-quarter earnings of $1.07 billion, or $0.61 per share, down from $1.32 billion, or $0.76 per share a year earlier. The earnings decline is weighing on the stock, which is down about 4% in Thursday morning trading. The report points to weaker near-term fundamentals, though no guidance details were provided.